Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review

INTRODUCTION: The World Health Organization (WHO) recommends that human papillomavirus (HPV) vaccination programs are established to be cost-effective before implementation. WHO recommends HPV vaccination for girls aged 9–13 years to tackle the high burden of cervical cancer. This review examined th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahumud, Rashidul Alam, Alam, Khorshed, Keramat, Syed Afroz, Ormsby, Gail M., Dunn, Jeff, Gow, Jeff
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266321/
https://www.ncbi.nlm.nih.gov/pubmed/32484811
http://dx.doi.org/10.1371/journal.pone.0233499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266321/
https://www.ncbi.nlm.nih.gov/pubmed/32484811
http://dx.doi.org/10.1371/journal.pone.0233499

Ejemplares similares